semaglutide cancer Could GLP-1 Drugs Reduce Obesity-Related Cancers in the Future? A growing body of research

Foundayo (orforglipron) Approved uses : Adults with obesity or adults with overweight and at least one weight-related condition

If youre curious whether GLP-1s make sense for you, our doctors can review your full health profile and talk through options, including whether medication or a different strategy is more appropriate: Weight Care at Alloy Weight Care at Alloy This answer was created using the following resources:

Cost: These treatments can be expensive, particularly IV NAD+ therapy, which requires medical supervision

No study has shown BPC-157 causes cancer in humans

Regulatory caution around medical adjacency, uneven long-term persistence on GLP-1 therapies, and the risk of superficial marketing claims can slow adoption

This information is especially important given the increasing rates of obesity and Type 2 diabetes in the United States, affecting millions and leading to various health complications